dual FXR/PPARδ agonist-2
dual FXR/PPARδ agonist-2 is a FXR/PPARδ dual agonist through hybridation of FXR agonist GW-4064 and PPARδ agonist GW-0742.dual FXR/PPARδ agonist-2 displays potent dual-target activities with a FXR agonistic EC50 of 12.28 nM and 69 % PPARδ activation at 100 nM. dual FXR/PPARδ agonist-2 shows anti-fibrotic effects in pulmonary fibrosis mouse model.
For research use only. We do not sell to patients.
- Formula: C26H29N7O5
- Molecular Weight:519.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
FXR 12.28 nM (EC50) |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Bleomycin (BLM) (HY-108345)-induced pulmonary fibrosis mice models[1]
-
Dosage:40 mg/kg
-
Administration:Intraperitoneally injection, daily for 21 days
-
Result:Reduced lesion density (fewer and smaller foci) and diminished septal thickening.
Suppressed collagen accumulation and fibrotic progression.
Attenuated α-SMA deposition.
Chemical Information
-
Molecular Weight 519.55
-
Formula C26H29N7O5
-
SMILES
CC1=NOC(C2=CC=C(C=C2)CN(C)C)=C1COC(N3CCN(CC3)C4=NN5C(C(O)=O)=CN=C5C=C4)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)